Edwards Lifesciences Statistics
Total Valuation
EW has a market cap or net worth of $47.44 billion. The enterprise value is $43.91 billion.
Important Dates
The last earnings date was Thursday, April 23, 2026, after market close.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EW has 576.54 million shares outstanding. The number of shares has decreased by -1.88% in one year.
| Current Share Class | 576.54M |
| Shares Outstanding | 576.54M |
| Shares Change (YoY) | -1.88% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | 0.22% |
| Owned by Institutions (%) | 90.48% |
| Float | 574.77M |
Valuation Ratios
The trailing PE ratio is 44.59 and the forward PE ratio is 26.86. EW's PEG ratio is 2.23.
| PE Ratio | 44.59 |
| Forward PE | 26.86 |
| PS Ratio | 7.53 |
| Forward PS | 6.74 |
| PB Ratio | 4.62 |
| P/TBV Ratio | 6.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.23 |
Financial Ratio History Enterprise Valuation
| EV / Earnings | 40.06 |
| EV / Sales | 6.97 |
| EV / EBITDA | 23.09 |
| EV / EBIT | 25.20 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | n/a |
| Interest Coverage | 85.43 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 21.14% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 9.35% |
| Revenue Per Employee | $393,969 |
| Profits Per Employee | $68,513 |
| Employee Count | 16,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, EW has paid $224.90 million in taxes.
| Income Tax | 224.90M |
| Effective Tax Rate | 17.33% |
Stock Price Statistics
The stock price has increased by +8.21% in the last 52 weeks. The beta is 0.95, so EW's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +8.21% |
| 50-Day Moving Average | 81.88 |
| 200-Day Moving Average | 80.97 |
| Relative Strength Index (RSI) | 53.41 |
| Average Volume (20 Days) | 5,468,095 |
Short Selling Information
The latest short interest is 9.33 million, so 1.62% of the outstanding shares have been sold short.
| Short Interest | 9.33M |
| Short Previous Month | 10.95M |
| Short % of Shares Out | 1.62% |
| Short % of Float | 1.62% |
| Short Ratio (days to cover) | 2.05 |
Income Statement
In the last 12 months, EW had revenue of $6.30 billion and earned $1.10 billion in profits. Earnings per share was $1.88.
| Revenue | 6.30B |
| Gross Profit | 4.91B |
| Operating Income | 1.74B |
| Pretax Income | 1.30B |
| Net Income | 1.10B |
| EBITDA | 1.90B |
| EBIT | 1.74B |
| Earnings Per Share (EPS) | $1.88 |
Full Income Statement Balance Sheet
The company has $4.23 billion in cash and $705.40 million in debt, giving a net cash position of $3.53 billion or $6.12 per share.
| Cash & Cash Equivalents | 4.23B |
| Total Debt | 705.40M |
| Net Cash | 3.53B |
| Net Cash Per Share | $6.12 |
| Equity (Book Value) | 10.34B |
| Book Value Per Share | 17.80 |
| Working Capital | n/a |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 159.15M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
Gross margin is 77.87%, with operating and profit margins of 27.65% and 17.39%.
| Gross Margin | 77.87% |
| Operating Margin | 27.65% |
| Pretax Margin | 20.59% |
| Profit Margin | 17.39% |
| EBITDA Margin | 30.17% |
| EBIT Margin | 27.65% |
| FCF Margin | n/a |